Important changes to S8 medicines approval requirements
The HealthPathways Schedule 8 (S8) medicines page has been updated to reflect important changes in S8 NSW Health approval requirements.
The HealthPathways Schedule 8 (S8) medicines page has been updated to reflect important changes in S8 NSW Health approval requirements. These changes commenced on the 5 November 2026 and have occurred due to implementation of a new Medicines, Poisons and Therapeutics Goods Act and Regulation in NSW.
Key changes for GP prescribers include:
- Removal of the requirement to include the NSW Health approval number on prescriptions for Schedule 8 psychostimulant medicines (dexamfetamine, methylphenidate, lisdexamfetamine)
- Changes to the circumstances in which a prescriber must seek approval to prescribe from NSW Health and expanded exemptions from approval requirements
- Changes to the definition of substance-dependence when determining the need for an approval. Substance-dependence is now defined per ICD-11 or DSM-5
- New standards for prescribing medicines under the Opioid Treatment Program
- New approval forms and requirements for supplementary information.
- self-prescribing of Schedule 8 and Schedule 4D medicines is no longer permitted
The updated Schedule 8 Medicines HealthPathway includes key information for use in a consult including referral navigation advice to support approval applications and additional requirements for PBS prescriptions as well as S8 medicine storage and destruction.